Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03469128
Other study ID # 2016-2017PTBUE
Secondary ID IRB Protocol CL-
Status Completed
Phase Phase 1
First received
Last updated
Start date January 1, 2016
Est. completion date January 1, 2020

Study information

Verified date March 2021
Source British University In Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present research was aimed at comparing the effects of Cognitive Processing Therapy (CPT) with the effects of Sertraline in treating patients who have dual diagnosis PTSD & SUD. The present study examines the extent to which CPT is effective in treating PTSD symptoms for patients with PTSD and SUD.


Description:

Patients with co-occurrence PTSD & SUD disorders were grouped into 3 groups: first: Cognitive Processing Therapy (CPT) in which participants completed 12 sessions of CPT. Second: were treated by Sertraline. Third: a placebo control group.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date January 1, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients diagnosed with SUD Exclusion Criteria: - Patients diagnosed with other psychotic disorders

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive processing therapy
Psychological treatment for patients suffering from PTSD and SUD symptoms.
Drug:
Sertraline
Sertraline for the treatment of post-traumatic stress and SU disorders
Other:
Placebo Control
Placebo Control

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
British University In Egypt

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire A psychological parameter will be measured to check the efficacy of CPT against medication for the treatment for co-current PTSD & SUD. The groups will be examined to show if any significant reductions in PTSD and SUD symptoms was obtained over time. 3 Months